Posts
February 08 2023
SINTX Technologies, Inc. announced the pricing of its public offering in the amount of $12,000,000. EGS acted as counsel to Maxim Group LLC, the sole placement agent in this offering.
February 08 2023
TransCode Therapeutics, Inc. announced the closing of its Registered Direct offering in the amount of $1,500,000. EG&S acted as counsel to the Placement Agent.
February 04 2023
CN Energy Group, Inc. announced the closing of its Underwritten offering in the amount of $10,000,000. EG&S acted as counsel to the Underwriter.
February 02 2023
T2 Biosystems, Inc. announced the closing of its Public Offering in the amount of $12,000,000. EG&S acted as counsel to the Placement Agent.
February 02 2023
Genetic Technologies Limited announced the closing of its Registered Direct offering in the amount of $5,000,000. EG&S acted as counsel to the Placement Agent.
February 01 2023
CN Energy Group Inc. announced the closing of its underwritten public offering in the amount of $10,000,000. EGS acted as counsel to Aegis Capital Corp., the sole book-running manager in the offering.
January 29 2023
Nuvve Holding Corp. announced the commencement of its At The Market Offering in the amount of $25,000,000. EG&S acted as counsel to the Sales Agent.
January 26 2023
Cingulate Inc. announced the commencement of its At The Market Offering in the amount of $2,650,000. EG&S acted as counsel to the Sales Agent.